These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19422092)

  • 1. How can we improve the translational landscape for a faster cure of type 1 diabetes?
    von Herrath M; Chan A
    J Clin Invest; 2009 May; 119(5):1061-5. PubMed ID: 19422092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 3. The art of the alliance.
    Menzel GE; Xanthopoulos KG
    Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275
    [No Abstract]   [Full Text] [Related]  

  • 4. Universities shun Europe's drug initiative.
    Gilbert N
    Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
    [No Abstract]   [Full Text] [Related]  

  • 5. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 8. Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    Ramsey BW; Nepom GT; Lonial S
    N Engl J Med; 2017 May; 376(18):1762-1769. PubMed ID: 28467868
    [No Abstract]   [Full Text] [Related]  

  • 9. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 10. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM; Rohrbaugh ML
    Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 13. Public-private relationships in biobanking: a still underestimated key component of open innovation.
    Hofman P; Bréchot C; Zatloukal K; Dagher G; Clément B
    Virchows Arch; 2014 Jan; 464(1):3-9. PubMed ID: 24337181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Professional translational research: a new hybrid paradigm in early drug discovery.
    Nussbaumer P; Klebl B
    Future Med Chem; 2015; 7(14):1879-89. PubMed ID: 26420644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescuing the Lost in Translation.
    Gehr S; Garner CC
    Cell; 2016 May; 165(4):765-70. PubMed ID: 27153487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funding bodies should foster partnerships between industry and academia.
    Tzircotis G; Hickson T; Foulkes I
    Nat Rev Cancer; 2021 Feb; 21(2):65-66. PubMed ID: 33398101
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.
    Bornstein SR; Licinio J
    Nat Med; 2011 Dec; 17(12):1567-9. PubMed ID: 22146467
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.
    Jones CL; Yeung BK; Manjunatha U; Shi PY; Bodenreider C; Diagana TT
    Nat Rev Drug Discov; 2015 Jun; 14(6):442-4. PubMed ID: 26027536
    [No Abstract]   [Full Text] [Related]  

  • 19. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.
    Ingrosso L; Rezza G; Pocchiari M; Garaci E
    Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.